Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Van Assche

Showing results (51-60 of 287) with videos related to

Pageof 29
Sort By:
Current Opinion in Gastroenterology|May 7, 2009
Immunosuppression in inflammatory bowel disease: traditional, biological or both?Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
Biologics : Targets & Therapy|August 27, 2009
Adalimumab in Crohn's diseaseGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Current Opinion in Gastroenterology|November 25, 2010
Inflammatory bowel disease and colitis: new concepts from the bench and the clinicSéverine Vermeire, Gert Van Assche, Paul Rutgeerts
Current Gastroenterology Reports|September 29, 2014
The use of prognostic factors in inflammatory bowel diseasesThomas Billiet, Marc Ferrante, Gert Van Assche
Journal of Crohn'S & Colitis|December 22, 2010
Reply to Dr. Caprilli et al.'s letterMarc Ferrante, Séverine Vermeire, Gert Van Assche, et al.
Journal of Gastroenterology|March 21, 2018
New treatment options for inflammatory bowel diseasesBram Verstockt, Marc Ferrante, Séverine Vermeire, et al.
Scandinavian Journal of Gastroenterology|September 27, 2018
When IBD is not IBDBram Verstockt, Séverine Vermeire, Gert Van Assche, et al.
Expert Opinion on Biological Therapy|November 8, 2016
Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel diseaseBram Verstockt, Gert Van Assche, Séverine Vermeire, et al.
Magnetic Resonance Imaging Clinics of North America|November 19, 2013
Magnetic resonance imaging of perianal fistulasDirk Vanbeckevoort, Didier Bielen, Ragna Vanslembrouck, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2005
Protein-losing enteropathy in Crohn's diseaseMarc Ferrante, Gert De Hertogh, Freddy Penninckx, et al.
Pageof 29

Showing results (51-60 of 287) with videos related to

Sort By:
Pageof 29
Current Opinion in Gastroenterology|May 7, 2009
Immunosuppression in inflammatory bowel disease: traditional, biological or both?Gert Van Assche, Séverine Vermeire, Paul Rutgeerts
Biologics : Targets & Therapy|August 27, 2009
Adalimumab in Crohn's diseaseGert Van Assche, Séverine Vermeire, Paul Rutgeerts
Current Opinion in Gastroenterology|November 25, 2010
Inflammatory bowel disease and colitis: new concepts from the bench and the clinicSéverine Vermeire, Gert Van Assche, Paul Rutgeerts
Current Gastroenterology Reports|September 29, 2014
The use of prognostic factors in inflammatory bowel diseasesThomas Billiet, Marc Ferrante, Gert Van Assche
Journal of Crohn'S & Colitis|December 22, 2010
Reply to Dr. Caprilli et al.'s letterMarc Ferrante, Séverine Vermeire, Gert Van Assche, et al.
Journal of Gastroenterology|March 21, 2018
New treatment options for inflammatory bowel diseasesBram Verstockt, Marc Ferrante, Séverine Vermeire, et al.
Scandinavian Journal of Gastroenterology|September 27, 2018
When IBD is not IBDBram Verstockt, Séverine Vermeire, Gert Van Assche, et al.
Expert Opinion on Biological Therapy|November 8, 2016
Biological therapy targeting the IL-23/IL-17 axis in inflammatory bowel diseaseBram Verstockt, Gert Van Assche, Séverine Vermeire, et al.
Magnetic Resonance Imaging Clinics of North America|November 19, 2013
Magnetic resonance imaging of perianal fistulasDirk Vanbeckevoort, Didier Bielen, Ragna Vanslembrouck, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2005
Protein-losing enteropathy in Crohn's diseaseMarc Ferrante, Gert De Hertogh, Freddy Penninckx, et al.
Pageof 29